National prevalence estimates of chlamydia and gonorrhoea in the Netherlands (PECAN): comparison of two national cross-sectional surveys
Rattachement africain : nl. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
OBJECTIVES: National prevalence estimates of chlamydia and gonorrhoea are essential to inform public health strategies and support evidence-based policy development. The aim was to generate national prevalence chlamydia and gonorrhoea estimates in 2022/2023, identify associated risk factors and compare prevalence over time. METHODS: Five years after the first survey in 2016/2017, a second national cross-sectional probability sample survey about sexual health among men and women aged 16-34 years in the Netherlands was conducted between October 2022 and March 2023. Sexually active survey participants were invited to participate in the prevalence study and received a home-based sampling kit. Returned samples were tested for chlamydia and gonorrhoea in a laboratory (ie, nucleic acid amplification test). Weighting techniques were used to correct for selective non-response. Multivariable logistic regression analyses were performed to identify risk factors of infection. RESULTS: Of 6277 survey participants invited for the prevalence study, 1142 (18.2%) returned a specimen. The weighted overall chlamydia prevalence was 3.5% (95% CI 2.3% to 5.4%), and prevalence was higher in younger age groups (<25 vs ≥25 years). Due to low numbers in other groups, risk factor analysis was only possible among women aged 18-24 years, where risk factors for chlamydia included being <20 years, vocational education, no steady relationship and condomless sex. As in 2016/2017, no gonorrhoea cases were detected in 2022/2023. Chlamydia prevalence and associated risk factors did not change, except for higher prevalence among university-educated individuals in 2022/2023. DISCUSSION: Chlamydia prevalence among young sexually active men and women in the Netherlands remained stable between 2016/2017 and 2022/2023, with higher prevalence observed in younger age groups in both studies. Given recent changes in chlamydia testing guidelines in the Netherlands towards more restrictive testing of asymptomatic individuals, probability sample surveys with laboratory-confirmed STI testing are crucial for monitoring prevalence trends and evaluating public health policy.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- National prevalence estimates of chlamydia and gonorrhoea in the Netherlands (PECAN): comparison of two national cross-sectional surveys
- Date Crossref
- 25/06/2026
- Éditeur
- BMJ
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
National Institute for Public Health and the Environment Centre for Infectious Disease Control pays non établi dans la noticeStructure de recherche
-
GGD Amsterdam pays non établi dans la noticeÉtablissement de santé
-
Public Health Service of Amsterdam pays non établi dans la noticeÉtablissement de santé
-
Rutgers Sexual and Reproductive Health and Rights pays non établi dans la noticeInstitution
-
Aidsfonds pays non établi dans la noticeOrganisation à but non lucratif
-
Netherlands Center for Occupational Diseases pays non établi dans la noticeStructure de recherche
-
Amsterdam University Medical Centers pays non établi dans la noticeÉtablissement de santé
-
Public Health Laboratory pays non établi dans la noticeStructure de recherche
-
Soa Aids Nederland pays non établi dans la noticeInstitution
-
Amsterdam Institute for Immunology & Infectious Diseases (AII) pays non établi dans la noticeStructure de recherche
-
Department of Internal Medicine pays non établi dans la noticeInstitution
Centre for Infectious Disease Control — National Institute for Public Health and the Environment, GGD Amsterdam et Public Health Service of Amsterdam, avec 8 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.